Chad Kimmitt

MD. Internist & Adult Thrombosis @CalDomMed (He/Him)

[Chad Kimmitt @kimmitt2winit]

Check out our patient safety simulation used to identify and support learners and recognizing and managing in-hospital, patient safety events!

https://t.co/Zhb96z80d3

[Chad Kimmitt @kimmitt2winit]

Congrats @LanaCastellucci and the group @uOttawaMed !!! COBRRA is here!

https://t.co/l9KzOnJE4g

[Marc Carrier @MarcCarrier1]

🆕 New in @JAMA_current

🧠🩸 Age-adjusted D-dimer works for DVT too!
In a multinational prospective study (n=3,205), an age-adjusted cutoff safely ruled out DVT, increasing exclusions by +7.4% with 0% failures at 3 months.
📉 Fewer scans, same safety.

https://t.co/dF7ZNfVOVh

[Katie Lin MD MPH 🇨🇦 @lilninjadoc]

Dear Albertans:

Your hospitals/ER's are getting destroyed by influenza A right now.

Hallways full.
Waiting rooms overflowing.
Short staffed due to illness.
Wait times >7h unless critically ill.

Wash your hands.
Mask up.
Stay home if sick.
Patience pls.
Doing our best.

[Thrombosis Canada @ThrombosisCan]

@LanaCastellucci takes the audience through her practice-changing COBRA study. #TCConf25

[Saveetha Medical (Official) @smc_simats]

World Thrombosis Day – October 13 🩸

Today, on World Thrombosis Day, let’s raise awareness about the silent yet serious condition — blood clots (thrombosis). Early detection, healthy lifestyle, and regular checkups can save lives. ❤️

[Marc Carrier @MarcCarrier1]

📢 New in @NEJM:
In patients with provoked VTE + enduring risk factors, extended low-dose apixaban (2.5 mg bid ×12 months) 🔒 reduced recurrent VTE risk by nearly 90% (1.3% vs 10.0%) 👉 HR 0.13
🩸 Major bleeding was rare (1 pt).
👉 https://t.co/IaXEQv8gQM

[NEJM Evidence @NEJMEvidence]

Learn more about the benefits, risks, pivotal trails, prescribing pearls, and areas of uncertainty related to the use of SGLT2i for adults with heart failure: https://t.co/DFaIAyPqsO

@FralickMike #Cardiology

[Medicine Pods @MedicinePods]

🎙️ @RoundsTable Listeners, Drs. @FralickMike & @JohnFralick8 discuss periop BP strategies (hypotension vs HTN avoidance) on delirium & 1-yr cognition after noncardiac surgery, plus PRN albuterol–budesonide for severe asthma exacerbations.
Listen now at https://t.co/DloH2rH4bd‼️

[Marc Carrier @MarcCarrier1]

📸 Ottawa Thrombosis teams enjoying a well-deserved night out and celebrating our successes at #ISTH2025!

Proud of the science, the collaboration, and this incredible group. 🩸🥂

[Marc Carrier @MarcCarrier1]

📢 Practice-changing data from the Adjust-DVT study!

✅ Age-adjusted D-dimer safely rules out DVT in low/non-high pretest probability patients
📉 Reduces unnecessary ultrasounds
🔍 +17% yield in patients ≥75 years

#ISTH2025 #DVT #Thrombosis #LessIsMore

[Tzu-Fei Wang @TzufeiWang]

Hot off the press! COBBRA trial showed that apixaban is associated with >50% reduced risk of clinically-relevant bleeding symptoms for acute VTE treatment. This can be practice changing!
@LanaCastellucci @RodgerMarc @canvector

[Professor Maha Othman @MahaOthman8]

Pleasure to interview the brilliant Dr.@MarcCarrier1 at our latest @ThrombosisCan clot conversation podcast

Extended anticoagulation with reduced-dose apixaban is noninferior to full-dose ;preventing recurrent VTE in cancer patients while resulting in less bleeding 🩸

[Alberta Health Services @AHS_media]

Alberta Health Services has been notified of 13 confirmed cases of measles in the community of Two Hills and one case in the Vegreville area. At least four of the individual cases have also been in public settings while infectious. Learn more at https://t.co/7BlJziy3tX

[Marc Carrier @MarcCarrier1]

Prof. @isabellemahe1 presents API-CAT at #ACC2025, published in @NEJM Extended anticoagulation with reduced-dose apixaban is noninferior to full-dose for preventing recurrent VTE, with less clinically relevant bleeding 🩸in patients with cancer.
https://t.co/vmDS2Ap7Uk

[Chad Kimmitt @kimmitt2winit]

@LauraRiveraMD Love the choice of mug!!

[The Intern At Work @InternAtWork]

Our best wishes go out to everyone participating in the R1 #CaRMSMatch tomorrow!🩺🥼 @CaRMS_CA

[Chad Kimmitt @kimmitt2winit]

@RebeccaLiedtke Congrats!!!

[Chad Kimmitt @kimmitt2winit]

@LanceShaver Congrats!! Welcome to the program, feel free to reach out with any questions!!!

[Chad Kimmitt @kimmitt2winit]

@LauraRiveraMD @DrMattHenschke Go Matt!!!